Net Income (Loss) Attributable to Parent in USD of Adicet Bio, Inc. from Q1 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Adicet Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2017 to Q3 2025.
  • Adicet Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$26.9M, a 11.9% increase year-over-year.
  • Adicet Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$115M, a 2.44% increase year-over-year.
  • Adicet Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$117M, a 17.9% increase from 2023.
  • Adicet Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$143M, a 104% decline from 2022.
  • Adicet Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$69.8M, a 12.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Adicet Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$115M -$26.9M +$3.62M +11.9% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 -$119M -$31.2M -$1.32M -4.4% 01 Apr 2025 30 Jun 2025 10-Q 05 Nov 2025
Q1 2025 -$117M -$28.2M -$198K -0.71% 01 Jan 2025 31 Mar 2025 10-Q 05 Nov 2025
Q4 2024 -$117M -$28.7M +$762K +2.58% 01 Oct 2024 31 Dec 2024 10-K 06 Mar 2025
Q3 2024 -$118M -$30.5M +$19.4M +38.9% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 -$137M -$29.9M +$2.5M +7.72% 01 Apr 2024 30 Jun 2024 10-Q 05 Nov 2025
Q1 2024 -$140M -$28M +$2.87M +9.28% 01 Jan 2024 31 Mar 2024 10-Q 05 Nov 2025
Q4 2023 -$143M -$29.5M +$385K +1.29% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2025
Q3 2023 -$143M -$49.9M -$27.9M -127% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 -$115M -$32.4M -$9.87M -43.8% 01 Apr 2023 30 Jun 2023 10-Q 06 Nov 2024
Q1 2023 -$105M -$30.9M -$35.5M -769% 01 Jan 2023 31 Mar 2023 10-Q 06 Nov 2024
Q4 2022 -$69.8M -$29.9M -$14.1M -88.9% 01 Oct 2022 31 Dec 2022 10-K 19 Mar 2024
Q3 2022 -$55.7M -$22M -$7.98M -57% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 -$47.7M -$22.5M -$11.7M -108% 01 Apr 2022 30 Jun 2022 10-Q 08 Nov 2023
Q1 2022 -$36.1M $4.62M +$25.9M 01 Jan 2022 31 Mar 2022 10-Q 08 Nov 2023
Q4 2021 -$62M -$15.8M -$6.86M -76.5% 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023
Q3 2021 -$55.1M -$14M +$766K +5.18% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$55.9M -$10.9M -$2.4M -28.4% 01 Apr 2021 30 Jun 2021 10-Q 08 Nov 2022
Q1 2021 -$53.5M -$21.3M -$16.8M -375% 01 Jan 2021 31 Mar 2021 10-Q 08 Nov 2022
Q4 2020 -$36.7M -$8.96M +$19.9M +69% 01 Oct 2020 31 Dec 2020 10-K 15 Mar 2022
Q3 2020 -$56.6M -$14.8M -$1K -0.01% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$56.6M -$8.46M -$5.8M -219% 01 Apr 2020 30 Jun 2020 10-Q 10 Nov 2021
Q1 2020 -$50.8M -$4.49M -$355K -8.59% 01 Jan 2020 31 Mar 2020 10-Q 10 Nov 2021
Q4 2019 -$50.5M -$28.9M -$23.1M -402% 01 Oct 2019 31 Dec 2019 10-K 12 Mar 2020
Q3 2019 -$27.3M -$14.8M -$6.37M -75.8% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 -$20.9M -$2.65M +$10.9M +80.5% 01 Apr 2019 30 Jun 2019 10-Q 05 Nov 2020
Q1 2019 -$31.9M -$4.13M +$5.73M +58.1% 01 Jan 2019 31 Mar 2019 10-Q 05 Nov 2020
Q4 2018 -$37.6M -$5.76M +$17.3M +75% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 -$54.9M -$8.41M -$5.1M -154% 01 Jul 2018 30 Sep 2018 10-K 12 Mar 2020
Q2 2018 -$49.8M -$13.6M -$9.53M -235% 01 Apr 2018 30 Jun 2018 10-K 12 Mar 2020
Q1 2018 -$40.3M -$9.86M -$6.5M -194% 01 Jan 2018 31 Mar 2018 10-K 12 Mar 2020
Q4 2017 -$33.8M -$23.1M 01 Oct 2017 31 Dec 2017 10-K 18 Mar 2019
Q3 2017 -$3.31M 01 Jul 2017 30 Sep 2017 10-K 18 Mar 2019
Q2 2017 -$4.06M 01 Apr 2017 30 Jun 2017 10-K 18 Mar 2019
Q1 2017 -$3.36M 01 Jan 2017 31 Mar 2017 10-K 18 Mar 2019

Adicet Bio, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$117M +$25.5M +17.9% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2025
2023 -$143M -$72.9M -104% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025
2022 -$69.8M -$7.79M -12.6% 01 Jan 2022 31 Dec 2022 10-K 19 Mar 2024
2021 -$62M -$25.3M -69% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023
2020 -$36.7M -$8.54M -30.4% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022
2019 -$28.1M -$18.8M -203% 01 Jan 2019 31 Dec 2019 10-K 12 Mar 2021
2018 -$9.3M +$24.5M +72.5% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021
2017 -$33.8M 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.